ai-se / loc_error2 Goto Github PK

View Code? Open in Web Editor NEW

0.0 4.0 0.0 1.28 MB

paper for ?IST

TeX 99.62% Makefile 0.17% Shell 0.21%

loc_error2's People

Contributors

Watchers

loc_error2's Issues

fig:jur undefined

LaTeX Warning: Reference fig:jur' on page 10 undefined on input line 1236. LaTeX Warning: Reference fig:jur' on page 10 undefined on input line 1280.
LaTeX Warning: Reference fig:jur' on page 11 undefined on input line 1290. LaTeX Warning: Reference fig:jur' on page 11 undefined on input line 1330.
LaTeX Warning: Reference `fig:jur' on page 14 undefined on input line 1650.

When I release this back to you: remove the two RHS IQR cols in fig8,9,10,11

they are not bad. its just that when i wrote my notes for those figures in the paper, there was nothing extra that had to be said from those columns.

When I release this back to you: spell check

misc things needed from jairus

what years for your data?
what does SRR PDR mean? i said SRR= pre-requirements and PDR=pre-coding
consider one of your numbers (e.g. 64%). does that mean predicted=100 and final = 164? or does it mean predicted = 100 and actual = 36? or is it (actual - predicted)/actual ?

papers needs about 1/4 page of references to people saying "sizing is a problem"

ideally a dozen papers saying that this sizing thing is a fatal flaw in cocomo, most horrid problem etc

this would be a section starting section2 called "motivation" before the current 2.2
places to start:

https://scholar.google.com/scholar?hl=en&q=%2Bproblems+++%2Bcocomo+%2Bestimating+%2Bsoftware+%2Bsize&btnG=&as_sdt=1%2C34&as_sdtp=

https://www.google.com/webhp?sourceid=chrome-instant&ion=1&espv=2&ie=UTF-8#q=%2Bproblems+++%2Bcocomo+%2Bestimating+%2Bsoftware+%2Bsize

Section references/

end of section 2.2 says

Only sections 3.2.1, 3.2.2, and two-fifths of the results in Figure 6 contain material found in prior papers.

but we have no 3.2.1 or 3.22

please fix

george.tex

george. please copy over our notes on the data sets, the perturbation study and the scott-knot method.

ensure your comments do the setup (with the data) . cpvers the stats methods, then discusses and explains all the results. note you need to end with the ``Results1'' bubble from p1.

cant see stuff on technical debt

handle jairus' inputs

need to recompute fig5 to be (p-a)/p

need another word for the opposite of agile

the opposite of an agile project.

can't be "big" cause agile folks claim they can do big

cant be "waterfall" cause that is too emotionally laden

the kind of software where early lifecycle estimates are essentila na dbudges cant really be altered much after the initial allocation

SA results

Mystery1

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,            40%:COCOMO2 ,   41 ,   50 (  --*----      |              ), 0.25,  0.41,  0.75
1 ,            20%:COCOMO2 ,   41 ,   57 ( ---*-----     |              ), 0.20,  0.41,  0.77
1 ,                COCOMO2 ,   43 ,   48 ( ----*--       |              ), 0.20,  0.43,  0.68
2 ,            60%:COCOMO2 ,   46 ,   54 (  ---*----     |              ), 0.25,  0.46,  0.79
2 ,            80%:COCOMO2 ,   50 ,   54 (  ----*--      |              ), 0.22,  0.50,  0.76
3 ,           100%:COCOMO2 ,   68 ,   59 (   -----*--    |              ), 0.29,  0.68,  0.88

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,                COCOMO2 ,    1 ,    1 (*              |              ), 0.01,  0.01,  0.02
2 ,            20%:COCOMO2 ,   13 ,   19 (-*             |              ), 0.07,  0.13,  0.26
3 ,            40%:COCOMO2 ,   28 ,   14 (  -*           |              ), 0.19,  0.28,  0.33
3 ,            60%:COCOMO2 ,   34 ,   44 (  -*---        |              ), 0.23,  0.34,  0.67
3 ,            80%:COCOMO2 ,   44 ,   39 (  --*-         |              ), 0.22,  0.44,  0.61
3 ,           100%:COCOMO2 ,   49 ,   32 (   --*-        |              ), 0.30,  0.49,  0.62

Mystery2

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,                COCOMO2 ,   13 ,   53 (*              |              ), 0.03,  0.13,  0.56
1 ,            20%:COCOMO2 ,   14 ,   53 (*              |              ), 0.05,  0.14,  0.58
1 ,            40%:COCOMO2 ,   19 ,   50 (*              |              ), 0.05,  0.19,  0.55
2 ,            80%:COCOMO2 ,   24 ,   57 (*              |              ), 0.07,  0.24,  0.64
2 ,            60%:COCOMO2 ,   25 ,   46 (*              |              ), 0.06,  0.25,  0.52
2 ,           100%:COCOMO2 ,   26 ,   71 (*              |              ), 0.07,  0.26,  0.78

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,                COCOMO2 ,    1 ,    2 (*              |              ), 0.00,  0.01,  0.02
2 ,            20%:COCOMO2 ,    8 ,   22 (*              |              ), 0.02,  0.08,  0.24
2 ,            40%:COCOMO2 ,   14 ,   42 (*              |              ), 0.04,  0.14,  0.46
3 ,            80%:COCOMO2 ,   25 ,   67 (*              |              ), 0.09,  0.25,  0.76
3 ,            60%:COCOMO2 ,   25 ,   79 (*              |              ), 0.06,  0.25,  0.85
3 ,           100%:COCOMO2 ,   30 ,   96 (*              |              ), 0.07,  0.30,  1.03

nasa93

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,                COCOMO2 ,   14 ,   39 (--*---         |              ), 0.04,  0.14,  0.43
1 ,            20%:COCOMO2 ,   14 ,   40 (--*---         |              ), 0.03,  0.14,  0.43
1 ,            40%:COCOMO2 ,   15 ,   43 (--*----        |              ), 0.04,  0.15,  0.47
1 ,            60%:COCOMO2 ,   16 ,   44 (--*----        |              ), 0.04,  0.16,  0.48
2 ,            80%:COCOMO2 ,   20 ,   40 (---*---        |              ), 0.06,  0.20,  0.46
2 ,           100%:COCOMO2 ,   27 ,   42 ( ---*--        |              ), 0.07,  0.27,  0.49

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,                COCOMO2 ,    1 ,    2 (*              |              ), 0.00,  0.01,  0.02
2 ,            20%:COCOMO2 ,    5 ,    8 (*              |              ), 0.01,  0.05,  0.09
3 ,            40%:COCOMO2 ,    8 ,   14 (-*             |              ), 0.02,  0.08,  0.16
4 ,            60%:COCOMO2 ,   12 ,   24 (--*-           |              ), 0.03,  0.12,  0.27
4 ,            80%:COCOMO2 ,   13 ,   28 (--*--          |              ), 0.04,  0.13,  0.32
5 ,           100%:COCOMO2 ,   19 ,   36 ( --*---        |              ), 0.06,  0.19,  0.42

coc81

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,                COCOMO2 ,    3 ,   18 (-*-----        |              ), 0.01,  0.03,  0.19
1 ,            40%:COCOMO2 ,    4 ,   16 (-*----         |              ), 0.02,  0.04,  0.18
1 ,            20%:COCOMO2 ,    4 ,   20 (-*-----        |              ), 0.01,  0.04,  0.21
2,            60%:COCOMO2 ,    6 ,   19 (--*----        |              ), 0.02,  0.06,  0.21
2 ,            80%:COCOMO2 ,    6 ,   21 ( -*------      |              ), 0.03,  0.06,  0.24
2 ,           100%:COCOMO2 ,    8 ,   18 ( -*----        |              ), 0.03,  0.08,  0.21

rank ,                   name ,    med   ,  iqr 
----------------------------------------------------
1 ,                COCOMO2 ,    0 ,    1 (*              |              ), 0.00,  0.00,  0.01
2 ,            20%:COCOMO2 ,    2 ,    4 (-*             |              ), 0.01,  0.02,  0.05
3 ,            40%:COCOMO2 ,    4 ,    7 (--*-           |              ), 0.02,  0.04,  0.09
4 ,            60%:COCOMO2 ,    6 ,   11 (--*---         |              ), 0.02,  0.06,  0.13
5 ,            80%:COCOMO2 ,    7 ,   15 (---*----       |              ), 0.02,  0.07,  0.17
5 ,           100%:COCOMO2 ,    8 ,   18 ( ---*-----     |              ), 0.03,  0.08,  0.21

can't see an answer to the following (in the bdy text)

"I missed a section discussing possible implications for researchers and practitioners. How the results of this work contribute to future research activities in the area? How practitioners can benefit from the results achieved in the paper?
You’re quite correct, there was no future work section in the paper. This has been included in the revised submission and appears in §7 (see Reviewer 1a)."

george's phone number